Nephrocare Health Serv L
NSE: NEPHROPLUS · Healthcare Service Provider · sector
₹607.40NSE close 2026-10-26
Key numbers
Market cap₹6,095 cr
Price₹607.40
52w high / low₹782 / ₹446
P/E71.6xSector median 22.9x
P/B5.5xSector median 2.0x
Book value₹111.3
Dividend yield–Sector median 0.55%
ROE6.9%Sector median 5.4%
ROCE13.4%Sector median 6.8%
OPM22.7%Sector median 15.9%
Debt / equity0.07xSector median 0.07x
EV/EBITDA25.3xSector median 17.2x
Interest cover2.7x
Current ratio2.80x
Sales growth 3y–Sector median +13.5%
Profit growth 3y–Sector median +26.9%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹426 cr vs borrowings ₹80 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 2.7x in the last 12 months.
- Other income was 32% of net profit in the last 12 months.
- No dividend in the last 1 financial years.
- Price ₹607.40 on 2026-10-26: -22.3% from the 52-week high, +36.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹743.10 · low ₹463.50
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Revenue | 260 | 266 | 282 |
| EBITDA | 61 | 54 | 64 |
| OPM % | 23.4% | 20.2% | 22.7% |
| Other income | 3 | 12 | 7 |
| Net profit | 32 | 30 | 32 |
| EPS (₹) | 3.43 | 3.03 | 3.19 |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 999 | 999 |
| EBITDA | 227 | 227 |
| Net profit | 77 | 77 |
| EPS (₹) | 8.48 | 8.48 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 1,116 |
| Borrowings | 80 |
| Cash & equivalents | 426 |
| Total assets | 1,471 |
| Fixed assets | 396 |
| Capital work in progress | 6 |
| Investments | 7 |
| Receivables | 317 |
| Inventory | 33 |
| Payables | 143 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | 233 |
| Cash from investing | -410 |
| Cash from financing | 157 |
| Capex | 119 |
| Free cash flow | 113 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 6.9% |
| ROCE % | 13.4% |
| Debtor days | 116 |
| Inventory days | 53 |
| Payable days | 230 |
| Cash conversion cycle (days) | -61 |
| Working capital days | 197 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 58.31% |
| FIIs | 11.73% |
| DIIs | 8.11% |
| of which Mutual funds | 3.93% |
| of which Insurance | 0.45% |
| Government | 0.00% |
| Public (non-institutions) | 21.85% |
| Quarter | Dec 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters % | 63.85% | 63.85% | 63.85% | 63.85% | 58.31% |
| Promoter group | % |
|---|---|
| Edoras Investment Holdings PTE Ltd | 26.56% |
| Vikram Vuppala | 9.41% |
| Bessemer Venture Partners Trust | 8.04% |
| Healthcare Parent Limited | 4.89% |
| Investcorp Private Equity Fund II | 4.48% |
| Quadria Capital India Fund III | 1.76% |
| VIRAAJ FAMILY TRUST (Trustee Ms. MANJU VUPPALA ) | 1.38% |
| MANVI FAMILY TRUST (Trustee Mr. VIKRAM VUPPALA) | 1.29% |
| Investcorp India Alternatives Fund - Investcorp GR | 0.47% |
| Pankaja Gatuku | 0.02% |
| Pullaiah Vuppala | 0.00% |
| Susheela Vuppala | 0.00% |
| Manju Kandagatla | 0.00% |
| Viraaj Vuppala | 0.00% |
| Manvi Vuppala | 0.00% |
| Public holders above 1% | % |
|---|---|
| Polar Capital Funds PLC - Healthcare Opportunities | 8.28% |
| Investcorp India Investments Holding Limited | 6.27% |
| International Finance Corporation | 3.07% |
| The Prudential Assurance Company Limited | 1.91% |
| 360 ONE Special Opportunities Fund - Series 9 | 1.30% |
| SBI Healthcare Opportunities Fund | 1.07% |
56,735 shareholders. Pledged: – of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | NEPHROPLUS |
| BSE code | 544647 |
| ISIN | INE428V01029 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.